| 產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱(chēng)及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購(gòu) |
|---|---|---|---|---|---|---|---|
| 201096-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-叔丁基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C41H47O4P | |
| 201096-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-叔丁基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C41H47O4P | |
| 201095-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(1-芘基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C53H39O4P | |
| 201095-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(1-芘基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C53H39O4P | |
| 201095-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(1-芘基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C53H39O4P | |
| 201094-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(1-芘基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C53H39O4P | |
| 201094-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(1-芘基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C53H39O4P | |
| 201094-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(1-芘基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C53H39O4P | |
| 201093-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-氯苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C33H29Cl2O4P | |
| 201093-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-氯苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C33H29Cl2O4P | |
| 201093-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-氯苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C33H29Cl2O4P | |
| 201092-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-氯苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C33H29Cl2O4P | |
| 201092-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-氯苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C33H29Cl2O4P | |
| 201092-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-氯苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C33H29Cl2O4P | |
| 201091-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(9-菲基)螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C49H39O4P | |
| 201091-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(9-菲基)螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C49H39O4P | |
| 201091-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(9-菲基)螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C49H39O4P | |
| 201090-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(9-菲基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
1G | 需詢(xún)價(jià) | C49H39O4P | |
| 201090-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(9-菲基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
100MG | 需詢(xún)價(jià) | C49H39O4P | |
| 201090-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(9-菲基)螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請(qǐng)咨詢(xún) 大賽璐 ≥98%,99%e.e. |
25MG | 需詢(xún)價(jià) | C49H39O4P | |
小泰
|
010-60710855
|